This 3-day event in Nyborg focuses on both basic and clinical aspects of research on personalized medicine.
The program includes talks and workshops within pharmacogenetics, drug interactions, epigenetics and other factors causing variation in drug response among individuals. The event will also focus on methods available across participating researchers.
Keynote speakers and plenary sessions
Keynote speakers include Ewan Pearson from Dundee University on “Pharmacogenetics of glucose-lowering drugs”, and Alex Sparreboom from Ohio University on “The role of drug transporters in chemotherapy-induced toxicity”. There will be plenary sessions on Novel methods for assessing drug toxicity, with confirmed speakers Deanna Kroetz, UCSF, and Magnus Ingelman-Sundberg, Karolinska Institutet, as well as Pharmacoepigenetics and biomarkers with confirmed speakers Ingolf Cascorbi, University of Kiel, Pascale Fisel, Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology Stuttgart, and Carmen Jerónimo, University of Porto. There will also be a session on Drug transporters with talks from Niels Jessen, Aarhus University and Mikko Niemi, University of Helsinki, and Personalized medicine in oncology with confirmed speaker Kjeld Schmiegelow, Copenhagen University Hospital.
Parallel session titles include Personalized medicine: Cardiovascular disease, Next generation sequencing and rare variants in personalized medicine, Role of the gut microbe in ADME, Pharmacogenetics and adverse drug reactions, New aspects of P450 variability and Using big data to develop personalized medicine.
Read more: norpm2018.com